Cross-national presence and sociodemographic correlates of the suicide crisis syndrome.


Journal

Journal of affective disorders
ISSN: 1573-2517
Titre abrégé: J Affect Disord
Pays: Netherlands
ID NLM: 7906073

Informations de publication

Date de publication:
15 05 2023
Historique:
received: 29 10 2022
revised: 14 02 2023
accepted: 17 02 2023
pubmed: 25 2 2023
medline: 22 3 2023
entrez: 24 2 2023
Statut: ppublish

Résumé

The Suicide Crisis Syndrome (SCS) has been proposed as an acute, pre-suicidal mental state that precedes imminent suicidal behavior; however, its cross-national applicability and sociodemographic correlates have not yet been determined. The present study assessed the presence and severity of the SCS in ten countries and examined several potential sociodemographic correlates (i.e., age, gender, marital status, race/ethnicity) of the SCS. 5528 community-based adults across 10 participating countries provided information on their SCS symptoms and sociodemographic characteristics in an anonymous online survey obtained via convenience sampling during the first year of the COVID-19 pandemic. The SCS occurred cross-nationally, with rates ranging from 3.6% (Israel) to 16.2% (Poland). Those in the United States, South Korea, Poland, and Turkey had the highest severity of symptoms. Participants who were older, identified as cisgender men, and married tended to have lower rates of the SCS than their respective counterparts. There were minimal differences in the SCS by race/ethnicity. These data were both cross-sectional and collected via convenience sampling, limiting generalizability of findings and information about the SCS's predictive utility. These findings support the cross-national presence of the SCS during the COVID-19 pandemic. Sociodemographic correlates aligned with those of suicidal behavior more generally, providing additional evidence for the concurrent/predictive validity of the SCS.

Sections du résumé

BACKGROUND
The Suicide Crisis Syndrome (SCS) has been proposed as an acute, pre-suicidal mental state that precedes imminent suicidal behavior; however, its cross-national applicability and sociodemographic correlates have not yet been determined. The present study assessed the presence and severity of the SCS in ten countries and examined several potential sociodemographic correlates (i.e., age, gender, marital status, race/ethnicity) of the SCS.
METHODS
5528 community-based adults across 10 participating countries provided information on their SCS symptoms and sociodemographic characteristics in an anonymous online survey obtained via convenience sampling during the first year of the COVID-19 pandemic.
RESULTS
The SCS occurred cross-nationally, with rates ranging from 3.6% (Israel) to 16.2% (Poland). Those in the United States, South Korea, Poland, and Turkey had the highest severity of symptoms. Participants who were older, identified as cisgender men, and married tended to have lower rates of the SCS than their respective counterparts. There were minimal differences in the SCS by race/ethnicity.
LIMITATIONS
These data were both cross-sectional and collected via convenience sampling, limiting generalizability of findings and information about the SCS's predictive utility.
CONCLUSIONS
These findings support the cross-national presence of the SCS during the COVID-19 pandemic. Sociodemographic correlates aligned with those of suicidal behavior more generally, providing additional evidence for the concurrent/predictive validity of the SCS.

Identifiants

pubmed: 36828142
pii: S0165-0327(23)00238-0
doi: 10.1016/j.jad.2023.02.076
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no conflicts of interest.

Auteurs

Megan L Rogers (ML)

Department of Psychology, Texas State University, San Marcos, TX, USA. Electronic address: megan.rogers@txstate.edu.

Lauren McMullen (L)

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.

Yinan Liang (Y)

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.

Nazareth Perez (N)

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.

Jenelle A Richards (JA)

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.

Gizem Akülker (G)

University of Health Sciences, Istanbul, Turkey.

Shira Barzilay (S)

Department of Community Mental Health, University of Haifa, Haifa, Israel.

Rabia Bilici (R)

University of Health Sciences, Istanbul, Turkey.

Yarden Blum (Y)

Department of Psychology, College of Management, Rishon LeZion, Israel.

Ksenia Chistopolskaya (K)

Eramishantsev Moscow City Clinical Hospital, Moscow, Russia.

Manuela Dudeck (M)

Department of Forensic Psychiatry and Psychotherapy, Ulm University, Germany.

M Ishrat Husain (MI)

Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada.

Oskar Kuśmirek (O)

Institute of Psychology, Polish Academy of Sciences, Warsaw, Poland.

Jhoanne M Luiz (JM)

Laboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.

Vikas Menon (V)

Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Barbara Pilecka (B)

Jagiellonian University, Kraków, Poland.

Veronika Sadovnichaya (V)

Lomonosov Moscow State University, Moscow, Russia.

Larissa Titze (L)

Department of Forensic Psychiatry and Psychotherapy, Ulm University, Germany.

Samira S Valvassori (SS)

Laboratório de Psiquiatria Translacional, Programa de Pós-Graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense (UNESC), Criciúma, SC, Brazil.

Sungeun You (S)

Department of Psychology, Chungbuk National University, Cheongju, Chungbuk, South Korea.

Igor Galynker (I)

Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH